EPALRIDASE contains Epalrestat which belongs to the group of medicines called Aldose reductase inhibitors. It is used in the management of diabetic neuropathy. Diabetic neuropathy is a serious and common complication of type 1 and type 2 diabetes, which is a type of nerve damage that occurs due to long-term high blood sugar levels in diabetic patients that affects most often the legs and feet. It is generally characterized by symptoms such as numbness/reduced ability to feel pain or temperature changes, tingling/burning sensation, sharp pains/cramps, and muscle weakness.
No review given yet!
You need to Sign in to view this feature
This address will be removed from this list